NANO MRNA Co.,Ltd. Logo

NANO MRNA Co.,Ltd.

Biotech IP generator developing and licensing mRNA therapeutics using proprietary delivery systems.

4571 | T

Overview

Corporate Details

ISIN(s):
JP3651120002
LEI:
Country:
Japan
Address:
港区愛宕二丁目5番1号
Sector:
Mining and quarrying
Industry:
Mining of non-ferrous metal ores

Description

NANO MRNA Co., Ltd. is a biotechnology company specializing in the research and development of mRNA-based therapeutics and other nucleic acid medicines. Operating under an "IP Generator" business model, the company functions as a platform connecting drug discovery seeds with medical and development needs. Its core strategy involves creating intellectual property for novel therapies and then licensing them out to pharmaceutical partners for further development and commercialization. NANO MRNA leverages proprietary Drug Delivery System (DDS) technologies to advance its pipeline, which includes candidates for indications such as osteoarthritis and glioblastoma. Formerly Nanocarrier Co., Ltd., the company has repurposed its extensive R&D experience to focus on mRNA drug discovery. In addition to its R&D activities, the company also markets co-developed pharmaceutical products.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-11-14 07:34
Registration Form
確認書
Japanese 8.2 KB
2025-11-14 07:33
Interim Report
半期報告書-第30期(2025/04/01-2026/03/31)
Japanese 195.4 KB
2025-10-15 08:30
Registration Form
訂正有価証券届出書(参照方式)
Japanese 192.3 KB
2025-10-08 09:22
Registration Form
有価証券届出書(参照方式)
Japanese 205.3 KB
2025-07-18 08:30
Share Issue/Capital Change
臨時報告書
Japanese 28.4 KB
2025-07-01 08:30
Post-Annual General Meeting Information
臨時報告書
Japanese 25.9 KB
2025-06-30 08:33
Governance Information
内部統制報告書-第29期(2024/04/01-2025/03/31)
Japanese 22.8 KB
2025-06-30 08:31
Registration Form
確認書
Japanese 8.1 KB
2025-06-30 08:30
Annual Report
有価証券報告書-第29期(2024/04/01-2025/03/31)
Japanese 906.3 KB
2025-05-14 08:34
Regulatory News Service
臨時報告書
Japanese 18.7 KB
2025-02-14 07:38
Regulatory News Service
臨時報告書
Japanese 18.8 KB
2024-11-18 07:32
Regulatory News Service
臨時報告書
Japanese 18.6 KB
2024-11-14 07:03
Report Publication Announcement
確認書
Japanese 8.1 KB
2024-11-14 07:02
Interim Report
半期報告書-第29期(2024/04/01-2025/03/31)
Japanese 169.1 KB
2024-07-01 08:07
Post-Annual General Meeting Information
臨時報告書
Japanese 22.2 KB

Automate Your Workflow. Get a real-time feed of all NANO MRNA Co.,Ltd. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for NANO MRNA Co.,Ltd.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for NANO MRNA Co.,Ltd. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

B2B platform for Ukraine-Korea trade, investment, and post-war reconstruction.
South Korea
052770
IVISIONWORKS CO.,LTD. Logo
Accelerates social impact startups & develops digital therapeutics for cognitive rehabilitation.
South Korea
469750
A diversified, Asia-focused conglomerate with businesses in property, retail, auto, and more.
Bermuda
JARD
The world's largest uranium producer, managing the front-end of the global nuclear fuel cycle.
Kazakhstan
KZAP
KAINOS MEDICINE, INC. Logo
Develops small molecule drugs for neurodegenerative diseases, cancers, and infectious diseases.
South Korea
284620
Kanamoto Co., Ltd. Logo
Global provider of rental construction equipment, also selling used machinery and steel products.
Japan
9678
Keihan Holdings Co.,Ltd. Logo
A conglomerate integrating transport, real estate, and retail for regional development.
Japan
9045
Kezar Life Sciences, Inc. Logo
Developing novel small molecule therapies for immune-mediated diseases and oncology.
United States of America
KZR
KNT-CT Holdings Co.,Ltd. Logo
A travel holding company offering themed tours and corporate travel solutions to boost Japan tourism.
Japan
9726
KoBioLabs, Inc. Logo
Develops AI-driven microbiome therapeutics for immune, metabolic, and brain disorders.
South Korea
348150

Talk to a Data Expert

Have a question? We'll get back to you promptly.